Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Outline of Final Research Achievements |
We performed this study to elucidate the signaling mechanisms leading to mTOR via L-type amino acid transporter (LAT1) by means of comprehensive phosphoproteomics and LAT1 inhibitors, revealing the overview of cellular responses mediated by LAT1 and to examine the possibilities of LAT1 as a molecular marker for cancer therapy. We found that the leucine uptake by LAT1 not only controls the phosphorylated proteins related to the translation regulations but induces the protein phosphorylations responsible for various cellular responses such as transcription, cell cycle regulation and cell structures. Our results indicated that co-administration of known anti-cancer agents with LAT1 inhibitors may be useful for cancer therapy.
|